Trying to Conceive on a GLP-1: Washout Timing and the Fertility Evidence

The short version

If you are on a GLP-1 and hoping to get pregnant, the plan has two moving parts, and getting them in the right order matters. First, these drugs are not used in pregnancy, so conception is meant to follow a planned washout — the semaglutide label advises stopping at least two months before a planned pregnancy because the medication clears slowly¹, and the tirzepatide label carries the same discontinue-before-pregnancy logic³. Second, the reason a washout matters at all is that these drugs can quietly restore fertility: as weight and insulin resistance fall, ovulation can return — sometimes in women who assumed they could not conceive⁴. But here is the honest twist most coverage misses: a GLP-1 is not a fertility drug, and at least one large real-world study found semaglutide pretreatment was associated with slower, not faster, conception⁷. So the smart move is deliberate timing, not wishful thinking.

This is educational only, not medical advice.

The washout: why you stop before you try

GLP-1 medications linger. Semaglutide has a half-life of about a week, so it takes roughly a couple of months to substantially clear the body — which is exactly why the label advises discontinuing it at least two months before a planned pregnancy¹². Tirzepatide follows the same principle: stop it before attempting to conceive, on a timeline your prescriber sets³. The point of the washout is to avoid an active drug on board during the earliest, most vulnerable weeks of development — a window that often passes before a woman even knows she is pregnant. This is a plan to make with your clinician before you start trying, not a calculation to run after a positive test.

Why fertility can come back — especially with PCOS

The clearest lever a GLP-1 pulls is weight, and weight is deeply tied to ovulation. International guidance builds PCOS care around weight reduction precisely because losing weight can improve ovulation, insulin resistance, and metabolic markers⁵. As insulin resistance eases, circulating androgens tend to fall and the hormonal signaling that times ovulation can normalize — which is the proposed route by which cycles become more regular and fertility returns⁶. In PCOS trials, GLP-1s have been associated with more regular cycles, more ovulation, and higher pregnancy rates, particularly when combined with metformin⁶. Maternal-fetal medicine reviewers note the same real-world consequence: women previously diagnosed with irregular cycles and unable to conceive have experienced unplanned pregnancies while taking these medications⁴. If you have PCOS, our Ozempic for PCOS guide goes deeper on the weight-and-ovulation mechanism.

The honest counterpoint: a GLP-1 won't speed conception

It is tempting to read "restores ovulation" as "boosts fertility," but the direct evidence pushes back. In a real-world multicenter cohort of nearly 2,000 women with overweight or obesity and infertility, semaglutide pretreatment before fertility care was associated with lower and delayed pregnancy and live-birth rates compared with matched controls — not higher ones⁷. Miscarriage rates did not differ. The authors themselves call for confirmation and caution in preconception counseling⁷. The reasonable takeaway is not that a GLP-1 harms fertility, but that it is a weight-and-metabolic tool, not a conception accelerant — and that the value for a woman trying to conceive is the durable weight loss achieved and then maintained through the washout, not the drug itself at the moment of conception.

Contraception while you are still on it

Until you and your clinician start the planned washout, reliable contraception is part of the plan — because restored ovulation can outpace your expectations. There is also a molecule-specific wrinkle: tirzepatide (Zepbound/Mounjaro) can reduce the effectiveness of oral contraceptives because it slows gastric emptying, so its label advises a backup or non-oral method for four weeks after starting and after each dose increase³. Injectable semaglutide does not carry that warning. Our guide to GLP-1s and birth control breaks that difference down. The logic is the same either way: you want conception to happen on your timeline, after the washout — not as a surprise mid-treatment.

Building the timeline with a provider

A conception plan on a GLP-1 is a sequence: reach and stabilize your weight, confirm contraception is covering you until then, agree on a washout window (about two months for semaglutide¹, a prescriber-set window for tirzepatide³), start prenatal folate, and only then begin trying. A program that raises pregnancy intentions before the first dose — and maps this sequence with you — is practicing real medicine. That reproductive-aware oversight is part of what our Metabolic-Fit Score methodology rewards, and why clinician-led options such as CoreAge Rx rank near the top of our best GLP-1 providers for women; some links here earn us a referral fee. If a pregnancy happens before the washout, our guide to GLP-1s and pregnancy covers exactly what to do. This article is educational only and not medical advice.